Our Mission is to join biology and engineering to identify and prevent global infections.
Biological Mimetics, Inc. (“BMI”) was formed in 1996 to commercialize innovative pharmaceutical products that will improve the quality of life and overall state of public health by combating resistant and emerging diseases in human and veterinary medicine.
BMI has collaborated with partners who share our vision to take BMI's innovative and proprietary platforms to market. We believe that these technologies have the potential to become heavy hitters in the vaccine and rapid diagnostic areas. If you are interested in collaborating with BMI, please contact us at This email address is being protected from spambots. You need JavaScript enabled to view it. .
